MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or...

Gastroenterology 2017 / 04 Vol. 152; Iss. 5

MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic HCV Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure

Poordad, Fred, Pol, Stanislas, Asatryan, Armen, Buti, Maria, Shaw, David R., Hezode, Christophe, Lalezari, Jacob, Felizarta, Franco, Reindollar, Robert, Gordon, Stuart C., Pianko, Stephen, Fried, Mich
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)33570-9
Date:
April, 2017
File:
PDF, 890 KB
english, 2017
Conversion to is in progress
Conversion to is failed